Humacyte Debt-to-Assets Ratio Growth & History (HUMA)

Humacyte's debt-to-assets ratio was 0.56 for fiscal 2025.

View full Humacyte company overview

Humacyte annual debt-to-assets ratio history

Humacyte annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.56−0.03−5.54%
20242024-12-310.590.14+30.20%
20232023-12-310.450.35+324.65%
20222022-12-310.11−0.08−43.17%
20212021-12-310.19−0.08−30.62%
20202020-12-310.27

Humacyte debt-to-assets ratio trends

Over the last five fiscal years, Humacyte's debt-to-assets ratio increased from 0.27 to 0.56, a change of 0.29. The latest reported quarter, Q2 2026, shows 0.48.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Humacyte source filings ↗

Community posts

It’s quiet here.

No posts about HUMA yet. Start the conversation.

Write the first post